Nejat Akar Selected Research

factor V Leiden

8/2013	Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.
4/2012	The association of protease activated receptor 1 gene -506 I/D polymorphism with disease-free survival in breast cancer patients.
1/2012	The role of Factor V Leiden in adult patients with venous thromboembolism: a meta-analysis of published studies from Turkey.
1/2012	Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients.
12/2011	Factor V G1691A (Leiden) is a major etiological factor in Egyptian Budd-Chiari syndrome patients.
4/2011	Factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms and the risk of tamoxifen-associated thromboembolism in breast cancer patients.
12/2010	Factor V Leiden in an Urartian, dating back to 1000 BC.
12/2009	Diffuse cerebral infarct associated with factor V Leiden and prothrombin 20210A mutations in a patient with tetralogy of Fallot.
8/2009	Factor V Leiden and prothrombin G20210A polymorphisms are not associated with disease-free survival in breast cancer.
3/2009	The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nejat Akar Research Topics

Disease

17	Thrombosis (Thrombus) 11/2015 - 03/2003
13	Neoplasms (Cancer) 01/2021 - 01/2005
13	Stroke (Strokes) 09/2013 - 04/2004
8	Venous Thromboembolism 01/2018 - 02/2005
8	Breast Neoplasms (Breast Cancer) 04/2012 - 01/2003
8	Venous Thrombosis (Deep-Vein Thrombosis) 03/2012 - 01/2002
6	Hemorrhage 01/2020 - 11/2011
6	Inflammation (Inflammations) 01/2016 - 04/2007
6	Familial Mediterranean Fever (Periodic Disease) 11/2012 - 03/2003
5	Activated Protein C Resistance (APC Resistance) 11/2013 - 12/2003
4	Thrombophilia 11/2011 - 07/2002
4	Thromboembolism 04/2011 - 01/2003
4	Sepsis (Septicemia) 06/2010 - 01/2006
4	Amyloidosis 05/2006 - 04/2002
3	beta-Thalassemia (Cooley's Anemia) 01/2017 - 12/2003
3	Obesity 11/2011 - 10/2008
3	Infections 11/2011 - 09/2004
3	Myocardial Infarction 09/2011 - 10/2002
3	Hypertension (High Blood Pressure) 09/2011 - 10/2008
3	Pulmonary Embolism 02/2009 - 08/2004
2	Leukemia 01/2018 - 01/2012
2	Type I Plasminogen Deficiency 09/2016 - 07/2003
2	Sickle Cell Anemia (Hemoglobin S Disease) 04/2013 - 12/2011
2	Hemophilia A (Haemophilia) 06/2011 - 12/2003
2	Hypertriglyceridemia 01/2011 - 10/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2010 - 10/2009
2	Cerebral Infarction 12/2009 - 03/2007
2	Insulin Resistance 10/2008 - 03/2005
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2008 - 01/2005
2	Urinary Tract Infections (Urinary Tract Infection) 02/2008 - 09/2004
2	Necrosis 11/2007 - 03/2002
2	Anemia 06/2004 - 05/2002
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Afibrinogenemia (Fibrinogen Deficiency) 01/2020
1	Gout 08/2015
1	Gouty Arthritis 08/2015
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 03/2015
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2015
1	Purpura 03/2015
1	Thrombasthenia (Glanzmann Thrombasthenia) 01/2015
1	Thalassemia 04/2013

Drug/Important Bio-Agent (IBA)

21	factor V LeidenIBA 08/2013 - 05/2002
20	Prothrombin (Factor II)IBA 08/2013 - 03/2003
13	Factor V (Coagulation Factor V)IBA 11/2013 - 03/2003
9	Endothelial Protein C ReceptorIBA 03/2015 - 01/2006
8	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 04/2012 - 01/2009
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2011 - 03/2003
8	Factor VIII (Coagulation Factor VIII)IBA 10/2009 - 07/2002
5	Oxidoreductases (Dehydrogenase)IBA 01/2018 - 08/2006
5	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2005
5	Lipoprotein(a)IBA 10/2011 - 05/2002
5	CytokinesIBA 09/2011 - 01/2005
4	Hemostatics (Antihemorrhagics)IBA 11/2012 - 10/2011
4	Plasminogen Activators (Plasminogen Activator)IBA 07/2009 - 10/2006
3	Fibrinogen (Factor I)FDA Link 01/2020 - 02/2008
3	PAR-1 ReceptorIBA 04/2012 - 06/2011
3	plasma protein Z (protein Z)IBA 06/2010 - 09/2008
3	Plasminogen Activator Inhibitor 1IBA 07/2009 - 06/2004
3	Interleukin-6 (Interleukin 6)IBA 01/2006 - 01/2005
2	PlasminogenIBA 09/2016 - 07/2003
2	AnticoagulantsIBA 11/2015 - 04/2012
2	Colchicine FDA LinkGeneric 08/2015 - 04/2002
2	NucleotidesIBA 09/2013 - 06/2012
2	DNA (Deoxyribonucleic Acid)IBA 04/2013 - 12/2011
2	LipidsIBA 01/2013 - 12/2011
2	ankaferd blood stopperIBA 11/2012 - 11/2011
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2012 - 09/2004
2	Membrane Proteins (Integral Membrane Proteins)IBA 08/2012 - 03/2012
2	Biomarkers (Surrogate Marker)IBA 08/2012 - 05/2008
2	Blood Coagulation Factors (Coagulation Factor)IBA 06/2011 - 04/2003
2	Tamoxifen FDA LinkGeneric 04/2011 - 01/2003
2	HDL CholesterolIBA 01/2011 - 10/2008
2	Protein CIBA 12/2010 - 02/2009
2	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 05/2009 - 01/2009
2	Protein SIBA 02/2009 - 07/2002
2	HomocysteineIBA 02/2009 - 09/2006
2	Factor IX (Coagulation Factor IX)FDA LinkGeneric 02/2009 - 01/2006
2	Glucose (Dextrose)FDA LinkGeneric 10/2008 - 03/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2008 - 02/2007
2	Amyloid (Amyloid Fibrils)IBA 05/2006 - 03/2003
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 08/2004 - 10/2002
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Vitamin K FDA Link 01/2018
1	Warfarin (Coumadin)FDA LinkGeneric 01/2018
1	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 01/2018
1	beta-Globins (beta Globin)IBA 01/2017
1	Galectin 2 (LGALS2)IBA 01/2016
1	Interleukin-8 (Interleukin 8)IBA 01/2016
1	C-Type Lectins (C-Type Lectin)IBA 08/2015
1	Uric Acid (Urate)IBA 08/2015
1	IntegrinsIBA 01/2015
1	Serine (L-Serine)FDA Link 09/2013
1	Protein C InhibitorIBA 09/2013
1	AsparagineIBA 09/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	Branched-Chain Amino AcidsIBA 01/2013
1	RetinoidsIBA 01/2013
1	ProcalcitoninIBA 11/2012

Therapy/Procedure

5	Therapeutics 11/2015 - 05/2002
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2013